STEVEN BIXLER: Open Payments
NPI 1669782553 · WESTERVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,555 in 181 payments from 41 companies in 2025. Trend: 2023 $1,819 · 2024 $2,096 · 2025 $3,555
Food & beverage: $3,555
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 36 | $693 |
| Dexcom, Inc. | 14 | $308 |
| Amgen Inc. | 12 | $215 |
| Novo Nordisk Inc | 20 | $189 |
| Neurocrine BioSciences, Inc. | 7 | $187 |
| BETA BIONICS, INC. | 11 | $184 |
| Lilly USA, LLC | 7 | $146 |
| Novartis Pharmaceuticals Corporation | 5 | $122 |
| Insulet Corporation | 3 | $115 |
| Abbott Laboratories | 6 | $113 |
Products named: GVOKE HYPOPEN, Dexcom G6 Transmitter, CRENESSITY, iLet Bionic Pancreas, EVENITY, JARDIANCE, LEQVIO, Omnipod.
Industry payments across OH — which companies pay providers there.
